Visits: 470, Avg visit time (secs): 359,94 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 250 | 53,19% | |
| /msd/basic/efsd-msd-basic-rfa08.html | 37 | 7,87% |
| /pfizer/efsd-pfizer-rfa08.html | 24 | 5,11% |
| /msd/clinical/efsd-msd-clinical-rfa08.html | 15 | 3,19% |
| /lifescan/efsd-lifescan-rfa08.html | 12 | 2,55% |
| /sanofi-aventis/endocannabinoid/efsd-sanofi-aventis-ecs-rfa08.html | 9 | 1,91% |
| /msd/albert-renold/efsd-msd-arenold.html | 7 | 1,49% |
| /lilly/programme/efsd-lilly-rfa08.html | 7 | 1,49% |
| /programmes.html | 6 | 1,28% |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-mv-rfa08.html | 6 | 1,28% |
| /novo-t2/efsd-novo-t2-recipients.html | 6 | 1,28% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 259 | 55,11% |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-mv-rfa08.html | 35 | 7,45% |
| /lifescan/efsd-lifescan-rfa08.html | 19 | 4,04% |
| /msd/clinical/efsd-msd-clinical-rfa08.html | 10 | 2,13% |
| /regulations.html | 9 | 1,91% |
| /pfizer/efsd-pfizer-rfa08.html | 8 | 1,70% |
| /msd/albert-renold/efsd-msd-arenold.html | 8 | 1,70% |
| /lilly/fellowships/efsd-lilly-fship08.html | 7 | 1,49% |
| /amylin/efsd-amylin-rfa08.html | 7 | 1,49% |
| /pfizer/efsd-pfizer-recipients.html | 6 | 1,28% |
| /novartis/efsd-novartis-recipients.html | 6 | 1,28% |